DLGAP1 and Hypertension resistant to conventional therapy: Our GWAS findings, combined with pathway analyses, provide an insight that the DLGAP1 protein at the postsynaptic membrane in the central nervous system may contribute to driving resistant hypertension, and highlight the importance of the nervous system in the etiology of resistant hypertension.